Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses (Details)

v3.19.1
Accrued Expenses (Details) - USD ($)
Mar. 31, 2019
Dec. 31, 2018
Accrued Expenses [Line Items]    
Payroll and Benefits $ 345,423 $ 722,178
Professional Fees 112,284 165,894
Clinical Trials 111,631 212,540
Consulting 5,556 9,401
Short-Term Portion of Capital Financing Obligation 3,143 4,715
Total Accrued Expenses $ 578,037 $ 1,114,728